S&S INSIDER

Haemonetics (NYSE: HAE) announced, the U.S. Food and Drug Administration (FDA) has approved its PerQseal® Elite vascular closure system for large-bore arterial procedures. The approval expands the company’s portfolio of vascular closure technologies for structural heart and endovascular interventions in the United States, following its January 2026 acquisition of Vivasure Medical Limited.   PerQseal Elite provides sutureless vascular closure for procedures performed using 14–22 French (F) sheaths. Its fully bioabsorbable patch seals arterial openings from inside the vessel and does not leave a permanent implant. The system also allows physicians to assess bleeding control while maintaining guidewire access, with the option to reposition or recover the device before implant release. In the prospective, multicenter ELITE arterial study, major device-related vascular access site complications through 30 days were reported at 0%, while mean time to hemostasis was less than one minute.   Jan Hartmann, M.D., M.D., Senior Vice President and Chief Medical Officer at Haemonetics, described the FDA approval as an important milestone in the company’s strategy to expand its advanced vascular closure business. He said PerQseal Elite has the potential to simplify minimally invasive procedures, including transcatheter aortic valve replacement (TAVR), while supporting patient comfort and experience.   The approval strengthens Haemonetics’ position in the U.S. market for large-bore vascular closure devices and brings a bioabsorbable, patch-based approach to procedures used in structural heart and endovascular care. The system’s ability to support rapid hemostasis while preserving guidewire access may offer procedural advantages for clinicians. Haemonetics plans to present and discuss additional clinical data at the Transcatheter Cardiovascular Therapeutics (TCT) Conference at the end of October 2026.   #Haemonetics #PerQsealElite #FDAApproval #MedicalTechnology #MedTech #VascularClosure #Cardiology #StructuralHeart #Endovascular #HealthcareInnovation

HYOSUNG TNC CORPORATION has begun commercial production of bio-based 1,4-butanediol (bio-BDO) in Vietnam, marking a significant milestone in Chairman Hyun-Joon Cho’s strategy to expand the group’s sustainable materials business. Announced on October 19, 2026, the development establishes an integrated production network connecting sugarcane-derived raw materials to finished bio-based spandex fibers.   The Vietnam facility has an initial annual production capacity of 50,000 metric tons, supported by a planned US$1 billion investment. Hyosung intends to expand capacity in phases to 200,000 metric tons annually, depending on market demand. The plant produces bio-BDO by fermenting sugars derived from sugarcane, replacing fossil-based feedstocks used in conventional production. The resulting material is supplied to Hyosung’s Dong Nai operations, where it is converted into polytetramethylene glycol (PTMG), a key intermediate for manufacturing regen™ BIO spandex.   𝗛𝘆𝘂𝗻-𝗝𝗼𝗼𝗻 𝗖𝗵𝗼, Chairman of Hyosung, described the integrated production system as a core pillar of the group’s long-term growth strategy. He emphasized that Hyosung aims to build on its experience in bio-based fibers to develop the market and strengthen its position in premium textiles worldwide.   The integrated production model could strengthen raw-material supply reliability, improve manufacturing efficiency, and reduce transportation requirements across the company’s Vietnamese operations. By replacing fossil-derived feedstocks with renewable sugarcane-based inputs, Hyosung is positioning its bio-based materials portfolio for customers seeking traceable alternatives in apparel and other industrial applications.   #Hyosung #HyosungTNC #BioBasedMaterials #BioBDO #SustainableTextiles #BioSpandex #CircularEconomy #GreenChemistry #SustainableManufacturing #MaterialsInnovation

SI Group, a global developer and manufacturer of performance additives, process solutions, and chemical intermediates, announced the appointment of Marcello Boldrini as Chief Executive Officer, effective October 19, 2026. Boldrini succeeds David Bradley, who has served as President and CEO since 2019. The leadership transition comes as SI Group continues to strengthen its operating performance and advance its business priorities across global specialty chemicals markets.   Boldrini brings more than 30 years of leadership experience across the specialty chemicals and materials industries in Europe, Asia, and the Americas. Most recently, he served as CEO and a director of Kraton Corporation, where he led growth and transformation initiatives, including a Transformation Office that generated more than US$100 million in annual EBITDA improvements. His earlier leadership experience includes roles at Houghton International, Momentive/Hexion, and Ashland. He will be based at SI Group’s headquarters in The Woodlands, Texas.   Daryl Roberts, Member of the SI Group Board of Directors, welcomed Boldrini, citing his specialty chemicals expertise and track record in business growth, transformation, and operational improvement. The board expects his experience to support stronger performance, customer service, and execution of the company’s strategic priorities.   𝗠𝗮𝗿𝗰𝗲𝗹𝗹𝗼 𝗕𝗼𝗹𝗱𝗿𝗶𝗻𝗶, CEO of SI Group, said his initial priorities would include listening to employees and customers, working with the leadership team, and establishing clear business priorities. He emphasized safe and reliable operations, disciplined execution, and delivering customer value.   The appointment signals SI Group’s focus on operational discipline, business transformation, and customer commitments in the global specialty chemicals industry. Boldrini’s experience leading performance improvement initiatives could be relevant as the company seeks to strengthen efficiency and long-term competitiveness. The transition follows SI Group’s successful 2025 recapitalization, which the company’s board said strengthened its financial position and increased flexibility for the future.   #SIGroup #MarcelloBoldrini #LeadershipTransition #SpecialtyChemicals #ChemicalIndustry #BusinessTransformation #OperationalExcellence #Manufacturing #CorporateLeadership #IndustrialChemicals

Teradata (NYSE: TDC) announced on October 20, 2026, a new set of privacy, security, and data resiliency capabilities designed to protect sensitive enterprise information as organizations expand their use of artificial intelligence. The updates address growing challenges around identity exposure, data access governance, cybersecurity, and the availability of information powering AI models and agents.   The new capabilities include Poly-Anonymization® to reduce exposure of personally identifiable information while preserving analytical value, format-preserving encryption, and post-quantum security readiness through TLS 1.3 hybrid-key exchange. Teradata is also introducing native data protection controls, including dynamic data masking, data classification and tagging, and column-level encryption. For operational resilience, immutable backups and database-level high availability are designed to help organizations protect recovery points and maintain access to mission-critical workloads.   Sumeet Arora Chief Product Officer at Teradata, said traditional approaches that treat privacy, security, and resiliency as separate challenges are insufficient when AI moves sensitive data across users, applications, models, and agents. He emphasized the need for integrated protection that can evolve as enterprise AI environments become more complex.   Matthew Fleck Founder and CEO of Anonomatic, highlighted the challenge of enabling organizations to use sensitive individual-level data for AI without unnecessarily exposing personal identities. He explained that the Teradata-Anonomatic partnership aims to support enterprise-scale privacy while preserving the data relationships needed for analytics and AI applications.   The announcement reflects a broader shift toward treating data protection as a core component of enterprise AI infrastructure. By combining privacy controls, data-layer security, and cyber-recovery capabilities, Teradata aims to help organizations manage sensitive information while maintaining operational continuity. These capabilities may be particularly relevant for businesses handling regulated data or deploying AI across complex hybrid-cloud environments.   #Teradata #EnterpriseAI #DataSecurity #Cybersecurity #DataPrivacy #ArtificialIntelligence #PostQuantumSecurity #DataGovernance #CyberResilience #EnterpriseTechnology

Saxony Trade & Invest Corp. (WFS) and the Arizona Commerce Authority (ACA) are expanding cooperation between two major semiconductor industry hubs in Europe and the United States. Announced on October 19, 2026, the initiative aims to connect companies, research institutions, and industry stakeholders across both regions, building on discussions held during SEMICON West in San Francisco from October 13–15.   The collaboration comes as both regions expand semiconductor manufacturing capacity and related infrastructure. Arizona has attracted more than 70 semiconductor expansion and new-site projects since 2020, representing over US$314 billion in investment. In Saxony, Dresden is a major European microelectronics center, with investments including Infineon’s €5 billion Smart Power Fab, GlobalFoundries’ €1.1 billion site expansion, and the approximately €10 billion European Semiconductor Manufacturing Company (ESMC) project.   Thomas Horn, CEO of Saxony Trade & Invest, emphasized that expanding chip production requires parallel growth in supplier networks, research capabilities, skilled labor, and infrastructure. He noted that closer cooperation could improve access for Saxon companies to the U.S. semiconductor market while opening opportunities for Arizona businesses in Europe’s largest microelectronics hub.   Sandra Watson and CEO of the Arizona Commerce Authority, highlighted the value of building stronger connections among companies, research institutions, and talent pipelines across the Atlantic. She expressed support for advancing semiconductor innovation and industry leadership through closer regional ties.   The initiative could help strengthen semiconductor supply chains by improving cross-border access to manufacturing ecosystems, suppliers, research partners, and technical talent. As new fabrication facilities increase demand for equipment, materials, advanced packaging, and specialized workers, closer coordination between Saxony and Arizona may create additional commercial and research opportunities. The announcement signals an intention to deepen cooperation; specific joint projects or formal agreements were not detailed.   #Semiconductors #Saxony #Arizona #ChipManufacturing #SemiconductorIndustry #SupplyChain #Microelectronics #AdvancedManufacturing #ResearchAndDevelopment #GlobalTrade

Canaan Inc. (NASDAQ: CAN), a technology company specializing in high-performance computing chips and computing equipment has appointed KPMG LLP in Singapore as its independent auditor, effective immediately. The firm replaces KPMG Huazhen LLP and will audit Canaan’s consolidated financial statements for the fiscal year ending December 31, 2026. The appointment was approved by the company’s Audit Committee and Board of Directors following an evaluation process.   Canaan said the change reflects its increasingly international and diversified operations as it advances its energy-plus-compute strategy and expands its power infrastructure presence in North America. The company also stated that the previous auditor’s reports for 2024 and 2025 contained no adverse opinions or disclaimers, and that there were no reportable disagreements or events of the specified types during the relevant review period.   张楠赓, Chairman and CEO of Canaan, said the transition to KPMG in Singapore reflects the company’s evolving business and organizational footprint. He reaffirmed Canaan’s commitment to corporate governance, financial transparency, regulatory compliance, and strengthening the reporting infrastructure needed to support its international operations and long-term growth.   The appointment highlights the importance of financial reporting and governance as Canaan expands across computing technology and energy infrastructure. An independent auditor plays a central role in reviewing financial statements and supporting investor confidence in corporate disclosures. As Canaan develops its international operations, maintaining robust financial oversight will remain important for regulatory compliance, stakeholder transparency, and long-term business execution.   #Canaan #KPMG #CorporateGovernance #FinancialReporting #Auditing #Semiconductors #HighPerformanceComputing #EnergyInfrastructure #InvestorRelations #BusinessExpansion

Senderra Specialty Pharmacy has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), including a Distinction in Oncology. The recognition follows an independent evaluation against nationally recognized standards for specialty pharmacy quality, patient safety, and care delivery. The oncology distinction acknowledges Senderra’s specialized clinical oversight, medication management, patient education, adherence support, and care coordination for people undergoing complex cancer treatments.   Will Howard, CEO of Senderra Specialty Pharmacy, said the recognition reflects the team’s commitment to supporting patients navigating complex cancer therapies. He emphasized that Senderra’s role extends beyond dispensing medication to helping patients understand treatment, coordinate with care teams, and address barriers that could interrupt therapy.   The reaccreditation reinforces SenderraRx’s positioning in the specialty pharmacy sector, particularly in oncology care, where treatment complexity and continuity of medication access are critical. Maintaining recognized quality credentials from both ACHC and URAC can strengthen confidence among healthcare providers, payers, and pharmaceutical manufacturers while supporting coordinated patient services and adherence initiatives.   #SenderraRx #SpecialtyPharmacy #Oncology #Healthcare #PatientCare #PharmacyAccreditation #CancerCare #MedicationManagement #HealthcareQuality #PatientSupport

Olympus Corporation announced the U.S. launch of its BF-UCP190F peripheral endobronchial ultrasound (EBUS) bronchoscope on October 15, 2026. The new device is designed to help pulmonologists reach and collect biopsy samples from deeper lung regions, including segmental and sub-segmental airways, expanding Olympus’ portfolio for lung cancer diagnosis and staging.   Featuring a slim 5.9 mm outer diameter, the BF-UCP190F combines real-time ultrasound guidance with an extended reach into challenging areas of the lung. Its design includes 170-degree upward angulation, a 14-degree forward-oblique viewing angle, and compatibility with the ViziShot™ 2 25G EBUS-TBNA needle. The bronchoscope integrates with Olympus’ EVIS X1™ Endoscopy System and EU-ME3 Ultrasound Processor to support image-guided tissue sampling.   Thomas Gildea, Global Lead, Medical Affairs, Respiratory, Olympus Corp., highlighted the importance of extending EBUS technology beyond central airways. He explained that deeper access with real-time image guidance can help interventional pulmonologists diagnose and stage lung cancer while improving their understanding of pulmonary diseases.   𝗦𝗲𝗶𝗷𝗶 𝗞𝘂𝗿𝗮𝗺𝗼𝘁𝗼, Executive Officer and Surgical and Interventional Solutions Division Head at Olympus, said the new bronchoscope expands access to deeper lung regions and enables ultrasound-guided sampling to help physicians obtain critical diagnostic information for treatment decisions.   The launch strengthens Olympus’ position in interventional pulmonology by addressing the challenge of accessing and sampling peripheral lung lesions. By extending the reach of EBUS-guided biopsy, the BF-UCP190F could support diagnostic workflows that inform lung cancer staging and personalized treatment planning. The product also reinforces the role of minimally invasive, image-guided technologies in respiratory care.   #Olympus #MedicalTechnology #MedTech #Bronchoscopy #LungCancer #CancerDiagnostics #RespiratoryCare #Endoscopy #HealthcareInnovation #InterventionalPulmonology

CME Group is planning to launch tungsten futures by early Q1 2027, pending regulatory reviews. The new contracts will expand the exchange’s metals offerings and give market participants a financial instrument to manage exposure to tungsten prices. The global tungsten market produces approximately 85,000–95,000 metric tons annually and is valued at more than US$20 billion at current spot prices.   The contracts will be financially settled against Fastmarkets’ assessment of ammonium paratungstate (APT) tungsten prices on a duty-unpaid, cost-insurance-freight basis for Rotterdam and Baltimore. The launch addresses a gap in a market that has an active spot trade but no established futures market. CME Group also reported that daily trading volume across its precious and industrial metals businesses reached 1.2 million contracts during the first nine months of 2026, up 41% year over year.   Jin Hennig, Managing Director and Global Head of Metals at CME Group, said tungsten sits at the intersection of advanced manufacturing, semiconductor technologies, and geopolitics, with clients increasingly seeking tools to hedge price exposure and improve transparency. He added that the new futures contracts will expand CME Group’s critical-minerals and energy-transition metals offerings as global supply chains restructure.   Quentin Lamarche, CEO of TechMet SCM, described the contract as a new tool for managing commercial risks associated with physical tungsten trading and logistics. He noted that transparent forward pricing could help support more reliable, long-term Western supply chains.   #CMEGroup #Tungsten #CriticalMinerals #CommoditiesTrading #FuturesMarket #MetalsMarket #SupplyChain #RiskManagement #AdvancedManufacturing #Semiconductors

Shoplazza announced that it is working with TikTok to support new agentic commerce experiences designed to shorten the journey from product discovery to purchase. The collaboration aims to help merchants convert consumer interest generated through content and advertising into completed transactions by reducing friction in the online shopping process.   The collaboration supports TikTok’s Buy Direct and Shopping Assistant features, introduced on October 5, 2026. Buy Direct enables consumers to purchase products directly from brands within TikTok without being redirected to an external storefront, using the Universal Commerce Protocol (UCP) to connect with merchant systems. Shopping Assistant answers product-related questions using merchant-provided information, allowing shoppers to explore product details before completing checkout on the merchant’s website within TikTok’s in-app browser.   Chao Xu, Director at Shoplazza, said, “As platforms automate more decisions, performance increasingly depends on how well data, creative and checkout work together.” He highlighted the potential for TikTok’s shopping experiences to help merchants convert customer interest while using transaction data to inform more effective marketing decisions.   #Shoplazza #TikTok #AgenticCommerce #SocialCommerce #ArtificialIntelligence #Ecommerce #DigitalMarketing #OnlineShopping #RetailTechnology #CustomerExperience